Safety Analysis of a Prospective Phase 2 Trial of Hypofractionated Proton Therapy for Benign Intracranial Tumors

Authors
Category Primary study
ConferenceAmerican Society for Radiation Oncology
Year 2025
This article has no abstract
Epistemonikos ID: be06207ed6660dcea6fa1364874cf42d315e31c1
First added on: Nov 21, 2025